K.J. Harrison & Partners Inc Intellia Therapeutics, Inc. Transaction History

K.J. Harrison & Partners Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$9.44 - $15.58 $170,344 - $281,141	-18,045 Closed	0 $0
Q4 2018 Jan 24, 2019	SELL	$11.39 - $27.13 $153,765 - $366,255	-13,500 Reduced 42.8%	18,045 $246,000
Q2 2018 Jul 26, 2018	BUY	$20.02 - $30.79 $631,530 - $971,270	31,545 New	31,545 $863,000
Q1 2018 Apr 30, 2018	SELL	$19.43 - $34.95 $311,268 - $559,899	-16,020 Closed	0 $0
Q4 2017 Jan 26, 2018	BUY	$17.39 - $31.12 $278,587 - $498,542	16,020	16,020 $308,000

336

96.1M

1.06M

863K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $661M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

Stay updated on K.J. Harrison & Partners Inc with notifications on news.